121 related articles for article (PubMed ID: 24096581)
1. The association between the Arg280His polymorphism in the XRCC1 gene and the risk of hematological malignancies.
Tong X; Yang J; Peng Y; Shen J; Xiong T; Zhang Y; Fan H
Tumour Biol; 2014 Feb; 35(2):1687-93. PubMed ID: 24096581
[TBL] [Abstract][Full Text] [Related]
2. Study on the association between the Arg194Trp polymorphism in the XRCC1 gene and the risk of hematological malignancies.
Tang L; Xiong T; Jia Q; He Q; Tong X; Peng Y; Shen J; Yang J; Zhang Y
Tumour Biol; 2014 Apr; 35(4):3009-16. PubMed ID: 24414482
[TBL] [Abstract][Full Text] [Related]
3. The Arg399Gln polymorphism in the XRCC1 gene is associated with increased risk of hematological malignancies.
Du L; Liu Y; Xue P; Song C; Shen J; He Q; Peng Y; Tong X; Tang L; Zhang Y
Tumour Biol; 2015 Jun; 36(6):4545-54. PubMed ID: 25619474
[TBL] [Abstract][Full Text] [Related]
4. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
[TBL] [Abstract][Full Text] [Related]
5. Association between XRCC1 Arg280His polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis.
Xu W; Liu SA; Li L; Shen ZY; Wu YL
Genet Mol Res; 2015 Jun; 14(2):7122-9. PubMed ID: 26125922
[TBL] [Abstract][Full Text] [Related]
6. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
[TBL] [Abstract][Full Text] [Related]
7. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
8. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis.
Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C
Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722
[TBL] [Abstract][Full Text] [Related]
9. The XRCC1 Arg280His gene polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Li LP; Wu W; Li XH; Song SS
Asian Pac J Cancer Prev; 2013; 14(3):2033-6. PubMed ID: 23679314
[TBL] [Abstract][Full Text] [Related]
10. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.
Zhao DY; Cheng L; Yu J; Shen H
Cancer Biomark; 2014; 14(6):449-56. PubMed ID: 25335737
[TBL] [Abstract][Full Text] [Related]
11. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
Zhang H; Liu H; Knauss JL
Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
[TBL] [Abstract][Full Text] [Related]
12. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
[TBL] [Abstract][Full Text] [Related]
13. XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis.
Wang B; Wang D; Huang G; Zhang C; Xu DH; Zhou W
Int J Colorectal Dis; 2010 Mar; 25(3):313-21. PubMed ID: 20033188
[TBL] [Abstract][Full Text] [Related]
14. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis.
Wang L; Yin F; Xu X; Hu X; Zhao D
PLoS One; 2012; 7(4):e34897. PubMed ID: 22529951
[TBL] [Abstract][Full Text] [Related]
15. Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies.
Liu L; Miao L; Ji G; Qiang F; Liu Z; Fan Z
Mol Biol Rep; 2013 Jun; 40(6):3943-52. PubMed ID: 23271134
[TBL] [Abstract][Full Text] [Related]
16. The XRCC1 Arg280His polymorphism contributes to cancer susceptibility: an update by meta-analysis of 53 individual studies.
Zhang K; Zhou B; Wang Y; Rao L; Zhang L
Gene; 2012 Dec; 510(2):93-101. PubMed ID: 22975644
[TBL] [Abstract][Full Text] [Related]
17. XRCC1 Arg194Trp and Arg280His polymorphisms in bladder cancer susceptibility: a meta-analysis.
Liu C; Yin Q; Li L; Jiao G; Wang M; Wang Y
Crit Rev Eukaryot Gene Expr; 2013; 23(4):339-54. PubMed ID: 24266849
[TBL] [Abstract][Full Text] [Related]
18. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies.
Bao Y; Jiang L; Zhou JY; Zou JJ; Zheng JY; Chen XF; Liu ZM; Shi YQ
PLoS One; 2013; 8(5):e64851. PubMed ID: 23717668
[TBL] [Abstract][Full Text] [Related]
19. Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population.
Kumar A; Pant MC; Singh HS; Khandelwal S
Mutat Res; 2012 Jan; 729(1-2):24-34. PubMed ID: 21945240
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in the DNA repair gene, XRCC1 associate with non-Hodgkin lymphoma susceptibility: A systematic review and meta-analysis.
Li Y; Bai O; Cui J; Li W
Eur J Med Genet; 2016 Feb; 59(2):91-103. PubMed ID: 26723520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
